Myths and Shibboleths in Nephrology

Chapter 1 Myth: Urinary tract infection can lead to end-stage renal disease (ESRD)

Chapter 2 Myth: Kidney donation does not jeopardize function in the remaining kidney

Chapter 3 Myth: Hypertension imposes a risk of chronic kidney failure

Chapter 4 Myth: Angiotensin converting enzyme inhibitors (ACEi) are superior to other antihypertensive drugs because of their renoprotective properties

Chapter 5 Myth: Dietary protein restriction slows progression of renal insufficiency

Chapter 6 Myth: Plasmapheresis is beneficial in some renal disorders

Chapter 7 Myth: Urinary tract infection is more prevalent in diabetes

Chapter 8 Myth: Type 1 diabetes is more likely than type 2 diabetes to lead to nephropathy and ESRD

Chapter 9 Myth: Pharmacological strategies may prevent acute tubular necrosis (ATN)

Chapter 10 Myth: Intravenous iron may be hazardous in infected hemodialysis patients

Chapter 11 Myth: Peritoneal dialysis is equivalent to hemodialysis

Chapter 12 Myth: Rationing of ESRD treatment is an unavoidable reality

Chapter 13 Myth: Tacrolimus is superior to cyclosporine in renal transplantation

Chapter 14 Myth: Dialyzer re-use is safe and cost effective

Chapter 15 Myth: Living related pancreas after kidney transplantation is preferable to cadaveric simultaneous pancreas-kidney transplantation

Chapter 16 Myth: Administration of active vitamin D metabolites is beneficial in patients with advanced chronic renal failure (pre end-stage renal disease)

Chapter 17 Myth: Surgical intervention and prompt nephrectomy are preferred in emphysematous pyelonephritis

Chapter 18 Myth: Mortality in chronic hemodialysis is greater in the U.S. than in Europe and Japan

Chapter 19 Myth: A single hemodialysis treatment prevents uremic bleeding and restores platelet function

Chapter 20 Myth: Kidney biopsy is indicated in every case of lupus nephritis

Chapter 21 Myth: Indicators of glycemic control in diabetic ESRD patients should be equivalent to those utilized in earlier stages of diabetic nephropathy

Chapter 22 Myth: Fish oil is effective therapy for IgA nephropathy

Chapter 23 Myth: Physician assistants should replace nephrologists in dialysis units

Chapter 24 Myth: Patients with severe cerebrovascular accidents (CVA) require long-term bladder catheters

Chapter 25 Myth: Pre-transplant blood transfusions enhance renal allograft survival

Chapter 26 Myth: Hemoperfusion is superior to hemodialysis in the treatment of certain poisonings and/or drug overdoses

Chapter 27 Epilogue